Investor's Business Daily on MSN

Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled

Novo Nordisk stock reversed higher Wednesday, though the Wegovy and Ozempic maker cut its sales outlook for the third time ...

This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?

Eli Lilly just struck a major deal with the world's largest retailer. GLP-1 drugs may have uses beyond obesity and diabetes ...

White House nears deal to lower prices for weight loss drugs

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.
Everyday Health

Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...